Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone Sublingual Tablet in Acute Ischemic Stroke
CTR20191956Phase 3Active
- Sponsor
- Nanjing Baixinyu Pharmaceutical
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of edaravone in ischemic stroke, brain infarction, sponsored by Nanjing Baixinyu Pharmaceutical. Started Nov 2019; status: active.
02
Drugs
edaravone
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on CTR20191956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191956.